Dupilumab for management of capecitabine-induced hand-foot syndrome Journal Article


Authors: Nykaza, I.; Sanford, R.; Gordon, A.
Article Title: Dupilumab for management of capecitabine-induced hand-foot syndrome
Keywords: cancer chemotherapy; clinical article; aged; unclassified drug; case report; drug dose reduction; drug withdrawal; capecitabine; follow up; loading drug dose; symptom; celecoxib; diclofenac; emollient agent; lidocaine; drug dose increase; drug substitution; hand foot syndrome; metastatic breast cancer; disease exacerbation; clobetasol; supportive care; urea; erosion; hand-foot syndrome; betamethasone dipropionate; human; female; article; oncodermatology; biologics; dupilumab; toxic erythema of chemotherapy; zinc sulfate; halobetasol
Journal Title: JAAD Case Reports
Volume: 63
ISSN: 2352-5126
Publisher: Elsevier Inc.  
Date Published: 2025-01-01
Start Page: 105
End Page: 108
Language: English
DOI: 10.1016/j.jdcr.2025.06.027
PROVIDER: scopus
PMCID: PMC12336648
PUBMED: 40791757
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics